Search

Hauser, RA, J Bronzova, C Sampaio, AE Lang, O Rascol, A Theeuwes, and SV Van De Witte. 2009. “Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients With Advanced Parkinson’s Disease”. Eur Neurol.

Isaacson, SH, and RA Hauser. 2009. “Improving Symptom Control in Early Parkinson’s Disease.”. Ther Adv Neurol Disord.

Encarnacion, EV, and RA Hauser. 2008. “Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments”. Eur Neurol.

Schwarzschild, MA, SR Schwid, K Marek, A Watts, AE Lang, D Oakes, I Shoulson, A Ascherio, The Parkinson Study Group QE3 Investigators, and . 2008. “Serum Urate As a Predictor of Clinical and Radiographic Progression in Parkinson Disease.”. Arch Neurol.

Sullivan, KL, CL Ward, RA Hauser, and TA Zesiewicz. 2007. “Prevalence and Treatment of Non-Motor Symptoms in Parkinson’s Disease”. Parkinsonism Relat Disord.

Investigators, The NINDS NET-PD, and RA Hauser. 2007. “A Randomized Clinical Trial of Coenzyme Q10 and GPI-1485 in Early Parkinson’s Disease.”. Neurology.

Zesiewicz, TA, CL Ward, RA Hauser, J Sanchez-Ramos, JF Staffetti, and K Sullivan. 2007. “A Double-Blind Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor.”. Movement Disorders.

Taylor, JP, MM Hulihan, JM Kachergus, HL Melrose, SJ Lincoln, KM Hinkle, JT Stone, et al. 2007. “Leucine-Rich Repeat Kinase 1:  a Paralog of LRRK2 and a Candidate Gene for Parkinson’s Disease.”. Neurogenetics.

Hauser, RA. 2007. “Early Treatment of Parkinson’s Disease: How and When Should Therapy Be Initiated?”. Therapeutic Spotlight.

Lew, MF, RA Hauser, HI Hurtig, WG Ondo, J Wojcieszek, T Goren, and CJ Fitzer-Attas. 2010. “Long-Term Efficacy of Rasagiline in Early Parkinson’s Disease.”. Int J Neurosci.